TDC
HSTO

Thompson Davis & Co’s Histogen Inc. Common Stock HSTO Stock Holding History

Thompson Davis & Co’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8
Closed -$9K – 1213
2017
Q1 		$9K Sell
8
-2
-20% -$1.93K 0.01% 733
2016
Q4 		$11K Buy
+10
New +$4.54K 0.02% 687

Other funds holding HSTO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Thompson Davis & Co's HSTO Position: Q2 2017 in Review

Thompson Davis & Co sold out of Histogen Inc. Common Stock (HSTO) in Q2 2017, closing a stake of 8 shares — an estimated $9K sold.

Thompson Davis & Co first reported a position in HSTO in Q4 2016 and held it in 2 quarters. The position peaked at $11K in Q4 2016. 70 funds tracked by Wall St. Rank hold HSTO as of Q2 2017.

  • Thompson Davis & Co reported no remaining Histogen Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 8 Histogen Inc. Common Stock shares in Q2 2017, an estimated $9K.
  • Thompson Davis & Co first reported a position in Histogen Inc. Common Stock in Q4 2016 and held it in 2 quarters.
  • Thompson Davis & Co's Histogen Inc. Common Stock position peaked at $11K in Q4 2016.
  • 70 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2017.

Based on Thompson Davis & Co's 13F filing for Q2 2017, filed 10 Aug 2017.